Van Den Born Simon 4
4 · Marex Group plc · Filed Apr 22, 2026
Research Summary
AI-generated summary of this filing
Marex Group (MRX) President Simon Van Den Born Sells Shares
What Happened
Simon Van Den Born, President of Marex Group plc (MRX), reported open-market sales on April 20, 2026. He sold 12,624 shares at a weighted average price of $50.92 (proceeds $642,770) and 641 shares at a weighted average price of $51.71 (proceeds $33,146), for total proceeds of approximately $675,916. These were disposals (sales), not purchases.
Key Details
- Transaction date: 2026-04-20; Form 4 filed 2026-04-22 (timely).
- Lots: 12,624 shares @ $50.92 (range $50.51–$51.34) and 641 shares @ $51.71 (range $51.56–$52.115). Weighted-average prices reported; issuer/staff may request per-price breakdown.
- Total shares sold: 13,265; total proceeds ≈ $675,916.
- Footnote: Sales were effected pursuant to a Rule 10b5-1 trading plan entered 12/12/2025.
- Footnote: Filing notes 383,741 shares underlying deferred bonus awards are included in the reported share counts (contingent rights to receive shares upon vesting).
Context
This was a planned sale under a Rule 10b5-1 plan (pre-arranged trading plan), which is commonly used to execute sales at scheduled times and can reduce the likelihood the trades reflect ad-hoc insider views. The transaction is a sale (routine disposition) — not a purchase or option exercise — and does not by itself indicate the insider’s current view of the company’s prospects.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-04-20$50.92/sh−12,624$642,770→ 1,509,605 total - Sale
Ordinary Shares
[F1][F3][F4]2026-04-20$51.71/sh−641$33,146→ 1,508,964 total
Footnotes (4)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on December 12, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $50.51 to $51.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $51.56 to $52.115 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The number of ordinary shares reported herein includes 383,741 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.